SOCS1 silencing can break high-dose dendritic cell immunotherapy-induced immune tolerance

被引：7
|
作者：
Hu, Qinghai [2 ]
Qin, Xia [2 ]
Qian, Gaochao [2 ]
Jiang, Shan [2 ]
Li, Haiyan [2 ]
Jiang, Min [1 ,2 ]
Li, Xiaoyan [2 ]
Chen, Si-Yi [3 ]
Zang, Ying Qin [1 ,2 ]
机构：
[1] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai 200025, Peoples R China
[3] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA
来源：
MOLECULAR MEDICINE REPORTS | 2008年 / 1卷 / 01期
关键词：
dendritic cell; immune tolerance; immunotherapy; SOCS1;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：61 / 70
页数：10
相关论文
共 45 条
  • [41] Allogeneic immunotherapy by hematopoietic stem cell transplantation (ASCT) after reduced intensity conditioning (RIC) following high-dose chemotherapy for patients with acute myeloblastic leukemia (AML) in first complete remission (CR1): Reduced toxicity
    Blaise, D.
    Tabrizi, R.
    Faucher, C.
    Mohty, M.
    Bay, J.
    Marit, G.
    Furst, S.
    Charbonnier, A.
    Chabannon, C.
    Vey, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [42] Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)
    Nash, Richard
    Hutton, George J.
    Racke, Michael
    Popat, Uday
    Devine, Steven M.
    Georges, George
    Griffith, Linda
    Muraro, Paolo A.
    Openshaw, Harry
    Sayre, Peter
    Stuve, Olaf
    Arnold, Douglas
    Spychala, Meagan
    Lim, Noha
    Malhotra, Sachin
    Phippard, Deborah
    Wundes, Annette
    Kraft, George H.
    Bowen, James D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S129 - S129
  • [43] Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)
    Nash, Richard A.
    Hutton, George J.
    Racke, Michael K.
    Popat, Uday R.
    Devine, Steven M.
    Georges, George E.
    Griffith, Linda M.
    Muraro, Paolo A.
    Openshaw, Harry
    Sayre, Peter H.
    Stuve, Olaf
    Arnold, Douglas L.
    Spychala, Meagan
    Lim, Noha
    Malhotra, Sachin
    Phippard, Deborah
    Wundes, Annette
    Kraft, George H.
    Bowen, James D.
    BLOOD, 2012, 120 (21)
  • [44] Pilot trial of interleukin-1 with granulocyte colony-stimulating factor for the mobilization of progenitor cells in advanced breast cancer patients undergoing high-dose chemotherapy: Expansion of immune effectors within the stem-cell graft and post-stem-cell infusion
    Sosman, JA
    Stiff, P
    Moss, SM
    Sorokin, P
    Martone, B
    Bayer, R
    van Besien, K
    Devine, S
    Stock, W
    Peace, D
    Chen, Y
    Long, C
    Gustin, D
    Viana, M
    Hoffman, R
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (03) : 634 - 644
  • [45] THERAPY-INDUCED PH1 SUPPRESSION IN CHRONIC MYELOID-LEUKEMIA - MOLECULAR AND CYTOGENETIC STUDIES IN PATIENTS TREATED WITH ALPHA-2B IFN, HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM-CELL INFUSION
    LOCOCO, F
    MANDELLI, F
    DIVERIO, D
    ALIMENA, G
    DEFABRITIIS, P
    MELONI, G
    CEDRONE, M
    FRONTANI, M
    GUERRASIO, A
    SAGLIO, G
    BONE MARROW TRANSPLANTATION, 1990, 6 (04) : 253 - 258
12345